Corporate News 08-Jun-24
Lupin to transfer its trade generics biz in India to Lupin Life Sciences
On 07 June 2024, Lupin entered into business transfer agreement with Lupin Life Sciences, a wholly owned subsidiary, to carve out, its trade generics business in India, as a going concern, on a slump sale basis. The said carve out will be effective 01 July 2024.
Previous News
Market hits fresh life highs; Nifty ends above 24,000 level
( Market Commentary - The Week That Was 28-Jun-24 16:33 )
Lupin to pay fine of Euro 40 million to European Commission
( Corporate News - 28-Jun-24 09:08 )
Lupin gains on receiving EIR from USFDA for New Jersey facility
( Hot Pursuit - 24-Jun-24 10:32 )
Lupin allots 43,475 equity shares under ESOP
( Corporate News - 21-Jun-24 12:12 )
Lupin Ltd slips for fifth straight session
( Hot Pursuit - 18-Jun-24 13:35 )
Lupin appoints Abdelaziz Toumi as CEO of API CDMO arm
( Hot Pursuit - 17-Jun-24 12:28 )
Lupin appoints Abdelaziz Toumi as CEO of Lupin Manufacturing Solutions
( Corporate News - 17-Jun-24 12:05 )
Lupin Nagpur unit clears USFDA inspection
( Hot Pursuit - 14-Jun-24 11:24 )
Lupin's Nagpur facility successfully clears USFDA audit
( Corporate News - 14-Jun-24 10:25 )
Lupin to transfer its trade generics biz in India to Lupin Life Sciences
( Corporate News - 08-Jun-24 14:09 )
Lupin acquires Sanofi brands - Aarane™ and Nalcrom™
( Corporate News - 05-Jun-24 11:45 )
Other Stories
Macro Intl. revises board meeting date
29-Jun-24 11:01
NOCIL announces cessation of directors
29-Jun-24 10:56
Orient Cement acquires 28.52% stake in Ardeur Renewables
29-Jun-24 10:43
Epigral commissions CPVC Compound manufacturing plant at Dahej
29-Jun-24 10:30
Dabur India to table results
29-Jun-24 10:22
G M Polyplast to conduct board meeting
29-Jun-24 10:22
Nicco Uco Alliance Credit to hold board meeting
29-Jun-24 10:21
Rane Holdings schedules board meeting
29-Jun-24 10:21
Atlas Cycles (Haryana) to table results
29-Jun-24 10:21
Unichem Laboratories to hold AGM
29-Jun-24 10:20
Back
Top
